Sankalp Program for Thalassemia Cure

How are the transplants becoming safer - good news for patients who seek cure from thalassemia

It has been three years since the time Sankalp started the program for thalassemia cure. We started our bone marrow transplantations for patients who had a matched related donor only. Even in this selected group of patient, recent data shows that the team has achieved 95.5% disease free survival and 98.3% overall survival last year, building upon the success of previous years. Specially in the matched sibling context, the team improved disease free survival from 89.1% across the years to 98.3% for last year alone.

Skill building nurses for Pediatric Hematology/Oncology and Bone Marrow Transplantation - the next big initiative

BMT Ghana

Sankalp-People Tree Centre for Pediatric BMT is happy to enable Ms Elizabeth Arku from BMT Ghana to receive 20 days of intense training. BMT Ghana is planning to setup what is probably going to be the very first BMT centre in Sub-Saharan Africa later in 2018.